Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

At the end of December 1969 it was known to be unlikely that the Protein Fractionation Centre would begin production before the second half of 1973.

  • Read more about At the end of December 1969 it was known to be unlikely that the Protein Fractionation Centre would begin production before the second half of 1973.

Dr Maycock indicated that he expected one third of the plasma from England would be processed at Liberton.

  • Read more about Dr Maycock indicated that he expected one third of the plasma from England would be processed at Liberton.

The DHSS invested £400,000 in the Protein Fractionation Centre towards the capital costs.

  • Read more about The DHSS invested £400,000 in the Protein Fractionation Centre towards the capital costs.

It was considered that, as there was only a small possibility of expansion at Elstree, Edinburgh should be prepared to cope with the requirements of a larger part of England than originally intended so that the total growth of requirement could be handled by the two Blood Products Units. Dr Maycock considered that this approach to long-term planning was the only correct procedure.

  • Read more about It was considered that, as there was only a small possibility of expansion at Elstree, Edinburgh should be prepared to cope with the requirements of a larger part of England than originally intended so that the total growth of requirement could be handled by the two Blood Products Units. Dr Maycock considered that this approach to long-term planning was the only correct procedure.

It had been decided that 1,000 litres of fresh or fresh frozen plasma could be processed weekly by PFC, using pools of eight litres. This size of pool could be handled conveniently and quickly and was supported by clinicians using the material.

  • Read more about It had been decided that 1,000 litres of fresh or fresh frozen plasma could be processed weekly by PFC, using pools of eight litres. This size of pool could be handled conveniently and quickly and was supported by clinicians using the material.

The Scottish CMO, Sir John Brotherson, wrote from Scotland offering further support for blood product production capabilities south of the border.

  • Read more about The Scottish CMO, Sir John Brotherson, wrote from Scotland offering further support for blood product production capabilities south of the border.

The setting up of a Joint Steering Committee on Blood Products Production was precipitated by the grant of product licences to two commercial firms "which might entail large sums being spent by NHS authorities on these products."

  • Read more about The setting up of a Joint Steering Committee on Blood Products Production was precipitated by the grant of product licences to two commercial firms "which might entail large sums being spent by NHS authorities on these products."

Pressure on the Government to act on increasing the supply of plasma was exerted by clinicians, by the medical press, by NBTS, and by the advisory bodies which had been set up.

  • Read more about Pressure on the Government to act on increasing the supply of plasma was exerted by clinicians, by the medical press, by NBTS, and by the advisory bodies which had been set up.

It was not until 1965 that planning for a 1972 extension to the Blood Products Laboratory, which then followed, contemplated accommodating the fractionation of plasma on any scale. This was a necessary step in producing clotting factor concentrates, though the main reason for the expansion at the time was to produce more immunoglobulin to prevent rubella in pregnancy, following an outbreak.

  • Read more about It was not until 1965 that planning for a 1972 extension to the Blood Products Laboratory, which then followed, contemplated accommodating the fractionation of plasma on any scale. This was a necessary step in producing clotting factor concentrates, though the main reason for the expansion at the time was to produce more immunoglobulin to prevent rubella in pregnancy, following an outbreak.

The Scottish Home and Health Department suggested that there should be a management policy committee covering both the Blood Products Laboratory and the Protein Fractionation Centre to ensure that a common production policy would apply to both laboratories.

  • Read more about The Scottish Home and Health Department suggested that there should be a management policy committee covering both the Blood Products Laboratory and the Protein Fractionation Centre to ensure that a common production policy would apply to both laboratories.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 266
  • Page 267
  • Page 268
  • Page 269
  • Current page 270
  • Page 271
  • Page 272
  • Page 273
  • Page 274
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.